Skip to content

A Non-Therapeutic study to assess the Functionality of the Kona Renal Denervation System in Subjects Undergoing Diagnostic Angiography

A Non-Therapeutic Feasibility Pilot Study to Assess the Targeting and Tracking Functionality of the Kona Renal Denervation System in Subjects Undergoing Diagnostic Angiography

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000895987
Enrollment
10
Registered
2011-08-22
Start date
2011-10-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to research one aspect, the non-therapeutic targeting and tracking functionality, of the Kona Renal Denervation System. The research project is being conducted to gather information about how the system functions when placed in a clinical setting. Information gathered from this research project will be used for the development of the Kona Renal Denervation System.

Interventions

The Kona Renal Denervation System (RDS) is a focused therapeutic ultrasound system designed to administer catheter-guided, focused therapeutic ultrasound treatments to the sympathetic nerve complex of the renal artery to induce renal neurolysis (i.e., coagulation of the sympathetic nerves that innervate the kidneys). This Pilot study is intented to test the targeting and tracking function of the device only. The therapy (dosing) system components will be disabled in this pilot study. This re

The Kona Renal Denervation System (RDS) is a focused therapeutic ultrasound system designed to administer catheter-guided, focused therapeutic ultrasound treatments to the sympathetic nerve complex of the renal artery to induce renal neurolysis (i.e., coagulation of the sympathetic nerves that innervate the kidneys). This Pilot study is intented to test the targeting and tracking function of the device only. The therapy (dosing) system components will be disabled in this pilot study. This research study will add between 15 to 30 minutes to the scheduled diagnostic angiography.

Sponsors

Pacific Clinical Research Group
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

a. Subject is at least 18 years of age. b. Subject is scheduled to undergo elective, diagnostic angiography.

Exclusion criteria

a. Subject has a body weight > 150 kilograms. b. Subject is pregnant, nursing or intends to become pregnant during the trial period. c. Subject is currently enrolled in other potentially confounding research. d. Subject has any condition that, at the discretion of the investigator, would preclude participation in the trial.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026